XML 26 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Revenues $ 2,174 $ 25,562
Research and development expenses 415,039 425,117
Selling and marketing expenses 90,756 125,343
General and administrative expenses 251,869 500,155
Total operating expenses 757,664 1,050,615
Operating loss 755,490 1,025,053
Financing income, net 21,721 3,400
Loss for the period (733,769) (1,021,653)
Other comprehensive income:    
Foreign currency translation income (loss) 19,291 (33,148)
Comprehensive loss for the period (714,478) (1,054,801)
Net loss for the period attributable to common stockholders $ (714,478) $ (1,054,801)
Loss per share (Basic and Diluted) $ (0.00) $ (0.01)
Common shares used in computing loss per share (Basic and Diluted) 181,790,919 143,615,503